The global battle against plague, caused by Yersinia pestis, continues to drive innovation in both treatment and drug development. As public health systems evolve, so does the landscape of the Plague Treatment Market, which is witnessing transformative advancements in therapeutic approaches and market strategies. Overview of the Plague Market Historically, plagued was a devastating...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons, leading to muscle weakness, paralysis, and ultimately respiratory failure. The disease is often fatal within 3 to 5 years of diagnosis. Though the prevalence of amyotrophic lateral sclerosis is relatively low, with approximately 2 per 100,000 people affected annually, it continues to pose...